SI-BONE Increased FY23 Guidance After Fast Start

SI-BONE reported 1Q23 orthopedic sales of $32.7 million, +45.8% compared to the first quarter of 2021.

A stabilizing macro environment, robust surgeon engagement and reimbursement tailwinds helped drive the company to its highest-ever revenue quarter. It is the first time as a public company that SI-BONE’s first-quarter performance...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us